SALES
Cummins India Q4 Results: PAT grows to Rs 539 crore
Cummins India's profit after tax surged to Rs 538.86 crore in the March quarter, with expenses at Rs 1,829.19 crore compared to Rs 1,648.01 crore in the previous year.
Coworking co EFC January-March net profit up 205% at 27.94 crore
Segment-wise, the only listed co-working space company's rental business accounted for a major share of total revenue at Rs 69.95 crore followed by fit out contracts business at Rs 23.24 crore and Rs 5.92 crore from other businesses.
Apollo Hospitals Q4 results today: What to expect
Apollo Hospitals is expected to post healthy growth in core earnings for the quarter ended March 2024 due to improved ARPOB and Healthco operations. Analysts predict a 68% year-on-year growth in net profit for the fourth quarter.
Prestige Estates Q4 Results: Profit plunges 70% YoY to Rs 140 crore
Prestige Estates Projects Ltd has posted 70 per cent decline in consolidated net profit at Rs 140 crore for the quarter ended March 2024 on lower income. Its net profit stood at Rs 468.4 crore in the year-ago period.
Torrent Pharma board approves to raise Rs 5,000 crore
Torrent Pharmaceuticals, actively seeking to expand through acquisitions, has expressed interest in purchasing Mumbai-based pharmaceutical company JB Pharma, according to a report by ET on Friday.
Glenmark Pharma Q4 Results: Net loss widens to Rs 121 crore YoY
Glenmark Pharma Q4 Results: The rise in loss was on account of declining sales in the US and exceptional items. It had reported a net loss of Rs 34.5 crore in the corresponding quarter of the previous year. In FY24, Glenmark's consolidated revenue reached Rs. 11,813 crore, a 2% increase year-over-year. The company's EBITDA margin for the fiscal year was 10.1%, primarily due to a one-time impact on sales in the India business during the third quarter.
- Go To Page 1
United Spirits Q4 Results: Net profit jumps twofold to Rs 241 crore
Diageo-controlled liquor maker United Spirits Ltd on Friday reported a two-fold increase in consolidated net profit to Rs 241 crore for the March quarter.
Puravankara Q4 Results: Loss narrows to Rs 7 crore YoY; revenue shoots up 112% YoY
The firm has launched 12 projects with a saleable area of 9.47 million square feet, reinforcing its expansion into high- potential micro-markets for the fourth quarter (Q4FY24) ending March 31, 2024.
Starbucks’ FY24 losses widen to Rs 81.84 crore for India operations
Of its total loss, Tata Consumer bore Rs 40.91 crore. This is a significant increase compared to the previous year, when Starbucks reported a loss of Rs 24.97 crore on sales of Rs 1086.89 crore.
ITC Q4 Preview: Revenue to grow around 3% YoY; margins to contract
Brokerage firms expect that ITC will announce subdued revenue growth for the fourth quarter when it declares its results on May 23. Based on projections from different brokerages, it's anticipated that profits will see a modest 3% year-on-year increase, with the hotels segment expected to perform strongly. In the previous December quarter, ITC recorded a 6% rise in consolidated net profit, amounting to Rs 5,335 crore.
Gland Pharma Q4 Results: Firm misses profit view on higher employee costs
Indian generic injectables maker Gland Pharma reported fourth-quarter profit below estimates on Wednesday, as soaring employee expenses outweighed strong demand in its core markets.
Sun Pharma net profit jumps 34% YoY to Rs 2,654.6 crore in Q4FY24
Sun Pharma's Q4FY24 net profit rises 34% YoY to Rs 2654.6 crore, driven by increased sales of global specialty products. Interim dividend of Rs. 5 declared for FY24.
Jubilant FoodWorks Q4 Results: Profit jumps on steady demand
Jubilant FoodWorks reported a more-than-seven fold jump in quarterly profit on Wednesday as the Domino's Pizza's Indian franchisee booked an one-time gain and also benefited from steady demand.
Sun Pharma Q4 Results: Profit jumps 34% YoY to Rs 2,654 crore, meets Street estimates
Sun Pharma Q4 Results: The company's revenue rose 10% year-on-year to Rs 11,983 crore in the reporting quarter. It was Rs 10,931 crore a year ago. Its board has approved a final dividend of Rs 5 per share, which will be paid within the prescribed timeline. India formulations sales were Rs 3,707 crore for the fourth quarter, showing growth of 10% over Q4 last year and accounted for 31.4% of total consolidated sales for the quarter.
Eris Lifesciences Q4 Results: Net profit jumps over 29% to Rs 80 crore
The Ahmedabad-based drug maker reported a net profit of Rs 61.5 crore during the corresponding quarter of the previous year. Revenue of Q4FY 24 grew by 37% YoY to Rs 551 crore. The net debt on March 31 stood at Rs 2700 crore.
JK Tyre Q4 Results: Net profit zooms 54% YoY to Rs 172 crore
JK Tyre & Industries on Tuesday said its consolidated net profit increased 54 per cent to Rs 172 crore for the fourth quarter ended March 31, 2024, on account of higher sales. The tyre maker had reported a net profit of Rs 112 crore in the year-ago period.
LT Foods Q4 Results: Net profit rises 14% YoY on strong sales
LT Foods, owner of basmati rice brands 'Daawat' and 'Royal', on Friday posted a 14 per cent jump in consolidated net profit at Rs 150.24 crore for the fourth quarter of fiscal 2023-24 on robust sales. The company's profit stood at Rs 131.81 crore a year earlier.
India Cements Q4 Results: Net loss narrows to Rs 50.06 crore
The cement and clinker volume for the fourth quarter was 24.36 lakh tonne as compared to 27.85 lakh tonne in the same period of the previous year, it added.
GSK Pharma Q4 Results: Net profit rises 46% YoY at Rs 194.48 crore
The company had posted a net profit of Rs 133.43 crore in the corresponding quarter of the previous fiscal, GlaxoSmithKline Pharmaceuticals (GSK Pharma) said in a regulatory filing.
Zydus Lifesciences Q4 Results: Drug makers posts threefold YoY jump in net profit to Rs 1,182 crore
Zydus Lifesciences on Friday reported Rs 1,182 crore net profit in Q4FY24, a threefold year-on-year (YoY) jump led by growth in US, India, Europe and emerging market sales.
Zydus Q4 Results: Net profit surges 4-fold to Rs 1,182 crore; revenue at Rs 5,534 cr
Zydus Lifesciences on Friday said its consolidated net profit surged four-fold to Rs 1,182 crore for the fourth quarter ended March 31, 2024 on higher sales. The drug firm had reported a net profit of Rs 297 crore in the January-March quarter of the 2022-23 fiscal.
JSW Steel Q4 Results: Profit falls 64% YoY to Rs 1,299 crore
JSW Steel reported a 64% YoY drop in consolidated net profit to Rs 1,299 crore for March 2024, with revenue from operations at Rs 46,269 crore. The Board recommended a final dividend of Rs 7.30 per share, and the EBITDA margin was 13.2%. Details on operating profit, sales realisations, total sales volumes, exports, and production achievements were highlighted.
Thomas Cook India Group reports net profit of Rs 271 cr for FY24
On a quarterly basis, Thomas Cook India Group reported a total income of Rs 1693 crore for the quarter ended March 31, up from Rs 1324 crore. The company reported a net profit of Rs 58 crore for the quarter ended March 31, 2024, up from Rs 10.2 crore for the fourth quarter of fiscal year 2023.
Prism Johnson Q4 Results: Firm posts loss hurt by lower pricing in cement business
Net sales fell marginally to 20.46 billion rupees from 20.56 billion rupees a year ago. Revenue from Prism Johnson's largest segment, cement, declined 3.3%. Cement makers usually resort to price cuts in the March-quarter to boost sales volumes, in order to clear year-end inventory backlogs.
DLF Q4 Results: Net profit jumps 62% YoY to Rs 920.71 crore
Realty major DLF Ltd on Monday reported a 62 per cent increase in its consolidated net profit to Rs 920.71 crore in the quarter ended March on higher income amid strong housing sales. Its net profit stood at Rs 570.01 crore in the year-ago period.
Ajmera Realty Q4 Results: Net profit jumps 44% YoY to Rs 103 crore; sales value sees two-fold jump
Real estate developer Ajmera Realty & Infrastructure has reported 44% on-year increase in net profit for the financial year 2023-24 at Rs 103 crore on the back of robust growth in bookings.
Alembic Pharma Q4 Results: Posts higher profit on strong N.America sales
Alembic Pharma Q4 Results: Indian generic drugmaker Alembic Pharma reported a 17% rise in fourth-quarter profit on Thursday, driven by strong sales, especially in the key North American market.
Tripadvisor stock sinks 38% as panel rules out sale for now
Tripadvisor first disclosed in February that Liberty TripAdvisor Holdings, its controlling shareholder, had been approached by at least one bidder for its controlling stake in the travel agency.
Puma Q1 Results: German sportswear company returns to sales growth in Americas despite 'volatile' market
Currency-adjusted sales rose 0.5% to 2.10 billion euros ($2.26 billion), in line with the 2.1 billion expected by analysts, Refinitiv data showed.
Load More
